Halozyme Therapeutics (HALO) Assets (2010 - 2026)
Halozyme Therapeutics (HALO) reported Assets of $2.58 billion for Q2 2026, up 25.5% from $2.05 billion a year earlier but down 3.6% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Assets of $2.53 billion, up 22.4% from FY2024.
- Assets has a five-year compound annual growth rate of 34.2% (FY2020 to FY2025).
- By year, Assets came in at $2.06 billion in FY2024 (+19.1%), $1.73 billion in FY2023 (-5.9%), $1.84 billion in FY2022 (+66.7%) and $1.1 billion in FY2021 (+90.4%).
- Five-year quarterly Assets spans a low of $1.1 billion in Q4 2021 and a high of $2.67 billion in Q1 2026.
- Year over year, Assets has now increased in each of the last ten quarters, with growth averaging 16.1% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q3 2021 (growth of 126.2%); the low point was Q4 2023 (a decline of 5.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.67 billion (Q1 2026), $2.53 billion (Q4 2025) and $2.22 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 2.58 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Bn |
| Mar 31, 2026 | 2.67 Bn |
| Dec 31, 2025 | 2.53 Bn |
| Sep 30, 2025 | 2.22 Bn |
| Jun 30, 2025 | 2.05 Bn |
| Mar 31, 2025 | 2.20 Bn |
| Dec 31, 2024 | 2.06 Bn |
| Sep 30, 2024 | 2.12 Bn |
| Jun 30, 2024 | 1.97 Bn |
| Mar 31, 2024 | 1.84 Bn |
| Dec 31, 2023 | 1.73 Bn |
| Sep 30, 2023 | 1.89 Bn |
| Jun 30, 2023 | 1.81 Bn |
| Mar 31, 2023 | 1.70 Bn |
| Dec 31, 2022 | 1.84 Bn |
| Sep 30, 2022 | 1.86 Bn |
| Jun 30, 2022 | 1.78 Bn |
| Mar 31, 2022 | 1.16 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Sep 30, 2021 | 1.19 Bn |
API Access
Halozyme Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();